MRK Merck & Co
- 104.310
- +0.330+0.32%
Merck & Co News
Merck & Co | 8-K: Merck Announces Second-Quarter 2024 Financial Results
Merck & Co | 8-K: Poll Results of Merck & Co Meeting and Completion of Note Issuance
Merck & Co | 8-K: Merck Announces First-Quarter 2024 Financial Results
Merck & Co | DEFA14A: Others
Merck & Co | DEF 14A: Definitive information statements
Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Merck & Co | 8-K: Peter C. Wendell Gave Notice to Merck & Co., Inc. Of His Intention to Retire from the Board of Directors of the Company as of the Company’s 2024 Annual Meeting of Shareholders on May 28, 2024
Merck & Co | 8-K: Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
Merck & Co | 8-K: The Board of Directors of the Company Elected Dalton E. Smart III to Serve as Senior Vice President Finance – Global Controller of the Company
Merck & Co | 8-K: Merck Announces Third-Quarter 2023 Financial Results
Merck & Co | 8-K: Merck Announces Second-Quarter 2023 Financial Results
Merck & Co | 8-K: Poll Results of Merck & Co Meeting
Merck & Co | 8-K: Merck & Co closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.050% Notes due 2028
Merck & Co | 8-K: Merck Announces First-Quarter 2023 Financial Results
Merck & Co | DEFA14A: Others
Merck & Co | DEF 14A: Definitive proxy statements
Merck & Co | 8-K: Merck & Co Announces Fourth-Quarter and Full-Year 2022 Financial Results
Merck & Co | 8-K: Merck Announces Third-Quarter 2022 Financial Results
Merck & Co | 8-K: Current report
Analysis
Price Target
No Data
No Data
